The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results